Pro-inflammatory cytokines, such as IL-6, IL-1β, and TNF-α, are known to induce F3 gene expression in both immune and non-immune cells, potentially contributing to the thromboembolic events observed in COVID-19 patients, particularly in severe cases (39). This evidence concerns the gene IL1B and COVID-19.